Mullen James C insider trades
Mullen James C has filed 9 Form 4s with the SEC that we hold, for Editas Medicine, Inc. (EDIT) (CEO, Director) and Thermo Fisher Scientific INC. (TMO) (Director). Across all of them we count 0 purchases worth $0 and 2 sales worth $1.0M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 13,805 shares of Editas Medicine, Inc. worth $525.0K, dated 2021-10-18. The first filing on our record is dated 2021-10-04 and the latest 2025-05-22.
Editas Medicine, Inc. (EDIT)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-10-18 | S, sale reported on Form 4 | 13,805 | $525.0K | 2021-10-20 |
| 2022-01-03 | S, sale reported on Form 4 | 18,252 | $491.9K | 2022-01-04 |
Thermo Fisher Scientific INC. (TMO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1226288) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms